Dr. Dayan Goodenowe will be attending the Alzheimer’s Association International Conference (AAIC) in person in Denver July 26-30, 2021. He will present the results from our Alzheimer’s disease clinical trial with board certified neurologist Dr. Sheldon Jordan of the Neurological Associates of Santa Monica, California. The two presentations are:
- The Effect of Plasmalogen Precursor Supplementation on Blood Plasmalogen and C-Reactive Protein Level and Cognition in Cognitively Impaired Persons.
- The Effect of Plasmalogen Precursor Supplementation on Blood Catalase and Malondialdehye Levels in Cognitively Impaired Persons.
The results of the clinical trial will not be available to the public until the conference is over on July 30th.
For more information about the conference click here.